Biotech Startups
9,911 companies tagged Biotech, with their investors and founders.
Angiex develops Nuclear-Delivered Antibody-Drug Conjugate (ND-ADC) therapies for solid cancers, using a platform that delivers chemotherapeutic payloads to the nucleus of tumor cells and tumor blood vessel endothelial cells. Its lead asset, AGX101, is a TM4SF1-directed ADC in Phase 1 clinical development for advanced solid tumors.
2 investors
ANI.AI is a San Francisco research lab building a computational platform for longevity medicine that integrates deep multiomics, longitudinal digital phenotyping, and physician-supervised intervention into a unified model of an individual's biological state. It runs the ELITE healthspan intervention trial and an intervention layer (AgeBiotics) to make individual response to aging interventions measurable, working with research groups and clinical teams studying aging, cognition, muscle, immunity, metabolism, and microbiome.
2 investors
ANI Pharmaceuticals is a generic and specialty pharmaceutical company that develops, manufactures, and distributes prescription drugs across multiple therapeutic areas including generics, rare diseases, and established branded products.
2 investors
AnimalBiome develops microbiome testing and probiotic products for dogs and cats to improve digestive health and overall wellness. The company serves pet owners and veterinarians through science-based solutions focused on understanding and optimizing the pet gut microbiome.
2 investors
Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases. It uses a technology platform to discover active pharmaceutical ingredients designed for veterinary patients.
2 investors
Anodyne Nanotech develops the HeroPatch, a transdermal drug delivery system designed to replace traditional injections for chronic care treatments. The company focuses on simplifying medicine delivery through an alternative to needles and syringes.
2 investors
Ansun develops novel therapeutic treatments targeting viral diseases, particularly respiratory infections, through its proprietary sialic acid biology platform. The company focuses on unmet medical needs in immunocompromised and underserved patient populations.
2 investors
Antengene is a biopharmaceutical company that develops therapies for cancer, with a pipeline focused on hematologic malignancies and solid tumors including Claudin 18.2, CD73, PD-L1/4-1BB bispecific, and CD24-targeting candidates. It is listed on the Hong Kong Stock Exchange and works with global partners on oncology drug development.
2 investors
Developing products for diseases associated with inflammation. (NASDAQ: ANTH)
2 investors
Antler Bio develops RNA data analysis technology for dairy farmers, revealing gene expression patterns in farm animals to improve health, productivity and decision-making. The company's platform, EpiHerd, identifies the biological factors affecting animal performance including milk yield, fertility and feed efficiency.
2 investors
Anto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response. The company serves pharmaceutical and clinical research by combining AI with genomic and microbiome data.
2 investors
AorticLab develops medical devices and solutions for cardiovascular applications. The company focuses on innovative treatment platforms and educational programs for patients and healthcare professionals.
2 investors
APASOMICS develops Apasomes, a drug delivery system using hydroxyapatite nanospheres designed to deliver bone-targeting medications like bisphosphonates more effectively while reducing side effects, for patients with osteoporosis and other bone diseases.
2 investors
Apeiron Investment Group is a discretionary, multi-strategy investment firm managing approximately $7 billion, making direct investments in private and listed companies as well as anchor LP investments and GP stakes in emerging asset managers. It invests across sectors with a focus on biotech, fintech and crypto, deep tech, hospitality and sports, real estate, and natural resources, with a primary focus on the US.
2 investors
Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance. It applies this technology to develop technical reagents, shelf-stable enzymes for cosmetics, and pulmonary biologic therapeutics for its partners.
2 investors
Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics targeting thromboinflammatory and cardiovascular diseases. The company's lead candidate, APAC, is a heparin proteoglycan mimetic currently in clinical trials.
2 investors
Apnimed develops investigational oral pharmaceutical therapies for obstructive sleep apnea (OSA), including its lead clinical candidate AD109, a neuromuscular approach intended to treat undertreated and untreated OSA patients. It is a clinical-stage pharmaceutical company focused on sleep apnea.
2 investors
Apogee Therapeutics develops engineered antibody therapies to treat inflammatory and immune diseases with reduced injection frequency compared to existing treatments.
2 investors
Apoha develops a molecular science data class used to design medicines, food, and materials. It operates in the deeptech and biotech space focused on molecular data for R&D applications.
2 investors
Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases. The company leverages scientific expertise and infrastructure to advance novel therapeutics through preclinical and clinical development.
2 investors
Applyo-Jena manufactures molecular biology reagent mixtures and beads for PCR and isothermal amplification applications. The products are designed for research laboratories and diagnostic manufacturers, with formulations optimized for room-temperature stability and rapid assay setup.
2 investors
AptsciAptamer Science develops aptamer-based drug delivery and diagnostic platforms for precision medicine applications. The company specializes in cancer therapeutics using its proprietary ApDC (Aptamer-Drug Conjugate) technology, as well as early-stage lung cancer diagnostic kits and emerging programs in immunotherapy and metabolic disease.
2 investors
Medical device company developing a Smart External Drain for cerebrospinal fluid drainage and intracranial pressure monitoring.
2 investors
Aquit provides R&D services in bioinformatics, molecular biology, and antibody development to support companies and research centers advancing innovation in aquaculture. The company delivers scientific support including genome analysis and in vitro validation for sustainable alternatives to antibiotics in fish farming.
2 investors